CTCELLS, Inc. – Trademark Portfolio
Entity Type: 03
CTCELLS, Inc. holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 9 (Computers & Electronics) — 2 filings in this category. The portfolio also extends into Class 10 (Medical Apparatus) across 5 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include CTCELLS and CTCEPTOR. The owner is based in Daegu.
Hyeonpung-eup, Dalseong-gun
R7-208B, 333, Techno jungang-daero
Daegu 42988 , KR
Showing of trademarks Trademarks
Trademark Classifications
CTCELLS, Inc.'s trademark portfolio spans 5 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Advertising; business management; business administration; office functions
Scientific and technological services; industrial analysis and research services
Frequently Asked Questions
How many trademarks does CTCELLS, Inc. have?
CTCELLS, Inc. has 4 U.S. trademarks filed with the USPTO. Of these, 2 registered, 2 abandoned.
What trademark classes does CTCELLS, Inc. file in?
CTCELLS, Inc. files trademarks across 5 Nice Classification classes. The most active classes are Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 35 (Advertising & Business), Class 42 (Computer & Scientific), Class 40 (Treatment & Processing). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.
What are CTCELLS, Inc.'s most well-known trademarks?
CTCELLS, Inc.'s registered trademark portfolio includes well-known marks such as CTCELLS and CTCEPTOR. These are among 2 currently registered trademarks in the portfolio.
What is CTCELLS, Inc.'s trademark registration success rate?
CTCELLS, Inc. has a 50% trademark registration rate, with 2 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.